It has been revealed that CD24 is a highly expressed anti-phagocytic signal in ovarian cancer and breast cancer, demonstrating the therapeutic potential for CD24 blockade in cancer immunotherapy [100]. Here, CD24 is linked to ovarian carcinoma.